Geoffrey Clapp - 15 Apr 2025 Form 3 Insider Report for Progyny, Inc. (PGNY)

Role
Chief Product Officer
Signature
/s/ Mark Livingston, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
15 Apr 2025
Net transactions value
$0
Form type
3
Filing time
02 May 2025, 18:00:23 UTC
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Clapp Geoffrey Chief Product Officer C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK /s/ Mark Livingston, Attorney-in-Fact 02 May 2025 0002065409

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PGNY Common Stock 28,694 15 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PGNY Stock Option (Right to Buy) 15 Apr 2025 Common Stock 39,120 $20.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. 33% of the RSUs will vest on March 17, 2026, with the remainder vesting quarterly in equal installments thereafter through March 17, 2028, subject to the Reporting Person's continued service on each applicable vesting date.
F2 33% of the shares will vest on March 17, 2026, with the remainder vesting quarterly in equal installments thereafter through March 17, 2028, subject to the Reporting Person's continued service on each applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney. This Form 3 was filed late due to a delay in receiving EDGAR codes for Mr. Clapp.